30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

Anika Fully Launches TACTOSET in the U.S. -

Anika Therapeutics is commencing full U.S. commercial launch of TACTOSET surgically-delivered therapy for bone repair procedures, following initial launch in late 3Q19. TACTOSET combines calcium phosphate with hyaluronic acid to treat bone voids and skeletal defects caused by trauma or age-related degeneration, and is the company's first product to launch under its U.S.-based hybrid commercial model. The hybrid sales model will allow the product to launch in various phases and to scale where appropriate, as TACTOSET is introduced across multiple categories in the orthopedic segment. The commercial team gains more precise commercial control, including greater visibility on product demand, end-user activity and fulfillment.